TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,897 | -24.8% | 162,565 | +0.9% | 0.01% | -12.5% |
| Q2 2023 | $75,704 | -50.1% | 161,074 | -27.2% | 0.02% | -50.0% |
| Q1 2023 | $151,593 | -58.9% | 221,207 | +255.3% | 0.03% | -61.0% |
| Q4 2022 | $369,225 | -68.1% | 62,264 | -78.1% | 0.08% | -67.7% |
| Q3 2022 | $1,156,000 | -28.1% | 284,830 | +0.2% | 0.25% | -24.6% |
| Q2 2022 | $1,607,000 | +0.6% | 284,361 | +12.4% | 0.34% | +29.6% |
| Q1 2022 | $1,597,000 | -28.7% | 253,019 | +0.2% | 0.26% | -22.6% |
| Q4 2021 | $2,239,000 | +2.8% | 252,473 | -10.5% | 0.34% | +3.7% |
| Q3 2021 | $2,179,000 | -50.6% | 282,229 | -38.5% | 0.32% | -48.2% |
| Q2 2021 | $4,407,000 | -14.1% | 458,601 | +21.3% | 0.63% | -19.8% |
| Q1 2021 | $5,129,000 | +53.8% | 377,976 | +62.3% | 0.78% | +47.1% |
| Q4 2020 | $3,335,000 | -17.8% | 232,865 | +6.0% | 0.53% | -38.6% |
| Q3 2020 | $4,056,000 | +219.9% | 219,584 | -0.3% | 0.86% | +181.8% |
| Q2 2020 | $1,268,000 | – | 220,204 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 40,119 | $253,000 | 0.85% |
| GAGNON SECURITIES LLC | 253,019 | $1,597,000 | 0.26% |
| PRINCETON CAPITAL MANAGEMENT LLC | 125,968 | $795,000 | 0.25% |
| DRW Securities, LLC | 1,000,000 | $6,310,000 | 0.17% |
| CARLSON CAPITAL L P | 310,000 | $1,956,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 105,388 | $665,000 | 0.09% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $139,000 | 0.07% |
| Fermata Advisors, LLC | 23,848 | $150,000 | 0.06% |
| SANDERS MORRIS HARRIS LLC | 20,826 | $131,000 | 0.03% |
| Meridian Wealth Advisors, LLC | 11,500 | $73,000 | 0.02% |